Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT201 for insomnia disorder Phase II trial
CTR20150664Phase 2Completed
- Sponsor
- Jingxin Pharmaceutical
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimdazenil in Insomnia, sponsored by Jingxin Pharmaceutical. Started Oct 2015; status: completed.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20150664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150664.